We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eastman Chemical (EMN) Launches Fluid Genius for Engineers
Read MoreHide Full Article
Eastman Chemical Company (EMN - Free Report) recently launched Fluid Genius to optimize heat transfer fluid performance. It is a patent-pending product and equips engineers and operations managers with predictive analytics for heat transfer fluid performance optimization.
This product is unique to the market and combines AI with 50 years of Eastman expertise to monitor and maximize the life cycle of heat transfer fluids for various system applications.
Fluid Genius can project fluid life expectancy and suggest the viability of extension, while avoiding expensive, unplanned shutdowns. The technology provides easy access to customer fluid testing results that disclose forward-looking insights to plan proactively for maintenance. The product works for virtually any organic heat transfer fluid system.
The new product is designed for plant maintenance engineers and operations managers in all processing industries, including oil and gas, chemicals and polymer processing.
Eastman’s shares have surged 90.8% in the past year, compared with 66.8% rise of its industry.
Eastman Chemical, stated last month that it is seeing continued momentum in the second quarter as it gains from innovation, strong market recovery and lower operating costs from its operations transformation program.
The company expects adjusted earnings per share of between $8.25 and $8.75 for 2021. It also anticipates free cash flow to reach $1.1 billion for the year.
Eastman Chemical currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the basic materials space are Dow Inc. (DOW - Free Report) , Celanese Corporation (CE - Free Report) and Cabot Corporation (CBT - Free Report) .
Dow has a projected earnings growth rate of roughly 261.5% for the current year. The company’s shares have surged 91.4% in a year. It currently flaunts a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Celanese has an expected earnings growth rate of around 68.3% for the current year. The company’s shares have gained 90.8% in the past year. It currently sports a Zacks Rank #1.
Cabot has an expected earnings growth rate of around 126% for the current fiscal. The company’s shares have gained 77.9% in the past year. It currently flaunts a Zacks Rank #1.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Eastman Chemical (EMN) Launches Fluid Genius for Engineers
Eastman Chemical Company (EMN - Free Report) recently launched Fluid Genius to optimize heat transfer fluid performance. It is a patent-pending product and equips engineers and operations managers with predictive analytics for heat transfer fluid performance optimization.
This product is unique to the market and combines AI with 50 years of Eastman expertise to monitor and maximize the life cycle of heat transfer fluids for various system applications.
Fluid Genius can project fluid life expectancy and suggest the viability of extension, while avoiding expensive, unplanned shutdowns. The technology provides easy access to customer fluid testing results that disclose forward-looking insights to plan proactively for maintenance. The product works for virtually any organic heat transfer fluid system.
The new product is designed for plant maintenance engineers and operations managers in all processing industries, including oil and gas, chemicals and polymer processing.
Eastman’s shares have surged 90.8% in the past year, compared with 66.8% rise of its industry.
Eastman Chemical, stated last month that it is seeing continued momentum in the second quarter as it gains from innovation, strong market recovery and lower operating costs from its operations transformation program.
The company expects adjusted earnings per share of between $8.25 and $8.75 for 2021. It also anticipates free cash flow to reach $1.1 billion for the year.
Eastman Chemical Company Price and Consensus
Eastman Chemical Company price-consensus-chart | Eastman Chemical Company Quote
Zacks Rank & Other Key Picks
Eastman Chemical currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the basic materials space are Dow Inc. (DOW - Free Report) , Celanese Corporation (CE - Free Report) and Cabot Corporation (CBT - Free Report) .
Dow has a projected earnings growth rate of roughly 261.5% for the current year. The company’s shares have surged 91.4% in a year. It currently flaunts a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Celanese has an expected earnings growth rate of around 68.3% for the current year. The company’s shares have gained 90.8% in the past year. It currently sports a Zacks Rank #1.
Cabot has an expected earnings growth rate of around 126% for the current fiscal. The company’s shares have gained 77.9% in the past year. It currently flaunts a Zacks Rank #1.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>